CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.6158
-0.0042 (-0.68%)
At close: Feb 20, 2026, 4:00 PM EST
0.6200
+0.0042 (0.68%)
After-hours: Feb 20, 2026, 6:14 PM EST
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 57 employees as of December 31, 2024. The number of employees decreased by 18 or -24.00% compared to the previous year.
Employees
57
Change (1Y)
-18
Growth (1Y)
-24.00%
Revenue / Employee
$43,421
Profits / Employee
-$213,333
Market Cap
8.87M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 57 | -18 | -24.00% |
| Dec 31, 2023 | 75 | 2 | 2.74% |
| Dec 31, 2022 | 73 | 7 | 10.61% |
| Dec 31, 2021 | 66 | 14 | 26.92% |
| Dec 31, 2020 | 52 | 14 | 36.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BiomX | 57 |
| Bolt Biotherapeutics | 40 |
| Quince Therapeutics | 36 |
| NuCana | 22 |
| SeaStar Medical Holding | 19 |
| BioVie | 13 |
| XTL Biopharmaceuticals | 10 |
| TransCode Therapeutics | 7 |
CLGN News
- 4 days ago - CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments - PRNewsWire
- 16 days ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING - PRNewsWire
- 3 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 3 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS - PRNewsWire
- 4 months ago - CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada - PRNewsWire
- 4 months ago - CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology - PRNewsWire
- 4 months ago - First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk - PRNewsWire
- 5 months ago - CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler - PRNewsWire